355 related articles for article (PubMed ID: 28919264)
1. Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action.
O'Leary KA; Shea MP; Salituro S; Blohm CE; Schuler LA
Stem Cell Reports; 2017 Oct; 9(4):1167-1179. PubMed ID: 28919264
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
3. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.
Arendt LM; Schuler LA
Am J Pathol; 2008 Jan; 172(1):194-202. PubMed ID: 18156207
[TBL] [Abstract][Full Text] [Related]
4. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.
Arendt LM; Evans LC; Rugowski DE; Garcia-Barchino MJ; Rui H; Schuler LA
J Endocrinol; 2009 Oct; 203(1):99-110. PubMed ID: 19635758
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environment.
Ding L; Shunkwiler LB; Harper NW; Zhao Y; Hinohara K; Huh SJ; Ekram MB; Guz J; Kern MJ; Awgulewitsch A; Shull JD; Smits BMG; Polyak K
PLoS Genet; 2019 Mar; 15(3):e1008002. PubMed ID: 30893315
[TBL] [Abstract][Full Text] [Related]
6. Delineating the epithelial hierarchy in the mouse mammary gland.
Asselin-Labat ML; Vaillant F; Shackleton M; Bouras T; Lindeman GJ; Visvader JE
Cold Spring Harb Symp Quant Biol; 2008; 73():469-78. PubMed ID: 19022771
[TBL] [Abstract][Full Text] [Related]
7. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
8. Interplay between progesterone and prolactin in mammary development and implications for breast cancer.
Lee HJ; Ormandy CJ
Mol Cell Endocrinol; 2012 Jun; 357(1-2):101-7. PubMed ID: 21945475
[TBL] [Abstract][Full Text] [Related]
9. Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.
Arendt LM; Kuperwasser C
J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):9-25. PubMed ID: 26188694
[TBL] [Abstract][Full Text] [Related]
10. The expression of estrogen, prolactin, and progesterone receptors in mammary gland and liver of female rats during pregnancy and early postpartum: regulation by thyroid hormones.
Varas SM; Jahn GA
Endocr Res; 2005; 31(4):357-70. PubMed ID: 16433254
[TBL] [Abstract][Full Text] [Related]
11. Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.
Nakles RE; Shiffert MT; Díaz-Cruz ES; Cabrera MC; Alotaiby M; Miermont AM; Riegel AT; Furth PA
Mol Endocrinol; 2011 Apr; 25(4):549-63. PubMed ID: 21292825
[TBL] [Abstract][Full Text] [Related]
12. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
[TBL] [Abstract][Full Text] [Related]
13. Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.
Tarulli GA; Laven-Law G; Shakya R; Tilley WD; Hickey TE
J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):75-91. PubMed ID: 26390871
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.
Arendt LM; Grafwallner-Huseth TL; Schuler LA
Am J Pathol; 2009 Mar; 174(3):1065-74. PubMed ID: 19179608
[TBL] [Abstract][Full Text] [Related]
15. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
16. Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.
O'Leary KA; Shea MP; Schuler LA
Adv Exp Med Biol; 2015; 846():201-20. PubMed ID: 25472540
[TBL] [Abstract][Full Text] [Related]
17. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.
Chamberlin T; D'Amato JV; Arendt LM
Breast Cancer Res; 2017 Nov; 19(1):128. PubMed ID: 29187227
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor antagonists reverse stem cell expansion and the paracrine effectors of progesterone action in the mouse mammary gland.
Ranjan M; Lee O; Cottone G; Mirzaei Mehrabad E; Spike BT; Zeng Z; Yadav S; Chatterton R; Kim JJ; Clare SE; Khan SA
Breast Cancer Res; 2021 Aug; 23(1):78. PubMed ID: 34344445
[TBL] [Abstract][Full Text] [Related]
19. Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo.
Boulanger CA; Rosenfield SM; George AL; Smith GH
J Mammary Gland Biol Neoplasia; 2015 Jun; 20(1-2):93-101. PubMed ID: 26362796
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors alpha and beta in rat decidua cells: cell-specific expression and differential regulation by steroid hormones and prolactin.
Tessier C; Deb S; Prigent-Tessier A; Ferguson-Gottschall S; Gibori GB; Shiu RP; Gibori G
Endocrinology; 2000 Oct; 141(10):3842-51. PubMed ID: 11014241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
